Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models

The toxicity of ionizing radiation is associated with massive apoptosis in radiosensitive organs. Here, we investigate whether a drug that activates a signaling mechanism used by tumor cells to suppress apoptosis can protect healthy cells from the harmful effects of radiation. We studied CBLB502, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2008-04, Vol.320 (5873), p.226-230
Hauptverfasser: Burdelya, Lyudmila G, Krivokrysenko, Vadim I, Tallant, Thomas C, Strom, Evguenia, Gleiberman, Anatoly S, Gupta, Damodar, Kurnasov, Oleg V, Fort, Farrel L, Osterman, Andrei L, DiDonato, Joseph A, Feinstein, Elena, Gudkov, Andrei V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 230
container_issue 5873
container_start_page 226
container_title Science (American Association for the Advancement of Science)
container_volume 320
creator Burdelya, Lyudmila G
Krivokrysenko, Vadim I
Tallant, Thomas C
Strom, Evguenia
Gleiberman, Anatoly S
Gupta, Damodar
Kurnasov, Oleg V
Fort, Farrel L
Osterman, Andrei L
DiDonato, Joseph A
Feinstein, Elena
Gudkov, Andrei V
description The toxicity of ionizing radiation is associated with massive apoptosis in radiosensitive organs. Here, we investigate whether a drug that activates a signaling mechanism used by tumor cells to suppress apoptosis can protect healthy cells from the harmful effects of radiation. We studied CBLB502, a polypeptide drug derived from Salmonella flagellin that binds to Toll-like receptor 5 (TLR5) and activates nuclear factor-κB signaling. A single injection of CBLB502 before lethal total-body irradiation protected mice from both gastrointestinal and hematopoietic acute radiation syndromes and resulted in improved survival. CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses. It is noteworthy that the drug did not decrease tumor radiosensitivity in mouse models. CBLB502 also showed radioprotective activity in lethally irradiated rhesus monkeys. Thus, TLR5 agonists could potentially improve the therapeutic index of cancer radiotherapy and serve as biological protectants in radiation emergencies.
doi_str_mv 10.1126/science.1154986
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4322935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>20054988</jstor_id><sourcerecordid>20054988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c621t-592e29b466eb9c7f9ffc8f4381f2650d7507f9d4b4d316b9e01860b013f903f93</originalsourceid><addsrcrecordid>eNpdkc9rFDEUx4Modq2ePalB0NvYl2Qmk1yEpagVVpTagreQybysWWcnazJb6H9vlh1q9RAeed9P3o98CXnO4B1jXJ5lF3B0WC5NrZV8QBYMdFNpDuIhWQAIWSlomxPyJOcNQNG0eExOmKpBtKAX5MdyHceQJxo9vYrDUK3CL6SX6HA3xUQbemEzvbR9iLsUJ3RTuEG6PIQw3dIw0i9xn5HasaffUtjaCUumxyE_JY-8HTI-m-Mpuf744er8olp9_fT5fLmqnORsqhrNkeuulhI77VqvvXfK10Ixz2UDfdtASfZ1V_eCyU4jMCWhAya8hnLEKXl_rLvbd1vsHY5TsoPZHYZJtybaYP5VxvDTrOONqQXnWjSlwNu5QIq_95gnsw3Z4TDYEctuhoNSrYAD-Po_cBP3aSzLGc5Eo6USbYHOjpBLMeeE_m4SBuZgmZktM7Nl5cXL-wv85WePCvBmBmx2dvDJji7kO44DV0y1deFeHLlNLtbd0-HQSBX91VH3Nhq7TqXG9XdefhLKhqWTEn8AAq-ytA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213596837</pqid></control><display><type>article</type><title>Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models</title><source>American Association for the Advancement of Science</source><source>Jstor Complete Legacy</source><source>MEDLINE</source><creator>Burdelya, Lyudmila G ; Krivokrysenko, Vadim I ; Tallant, Thomas C ; Strom, Evguenia ; Gleiberman, Anatoly S ; Gupta, Damodar ; Kurnasov, Oleg V ; Fort, Farrel L ; Osterman, Andrei L ; DiDonato, Joseph A ; Feinstein, Elena ; Gudkov, Andrei V</creator><creatorcontrib>Burdelya, Lyudmila G ; Krivokrysenko, Vadim I ; Tallant, Thomas C ; Strom, Evguenia ; Gleiberman, Anatoly S ; Gupta, Damodar ; Kurnasov, Oleg V ; Fort, Farrel L ; Osterman, Andrei L ; DiDonato, Joseph A ; Feinstein, Elena ; Gudkov, Andrei V</creatorcontrib><description>The toxicity of ionizing radiation is associated with massive apoptosis in radiosensitive organs. Here, we investigate whether a drug that activates a signaling mechanism used by tumor cells to suppress apoptosis can protect healthy cells from the harmful effects of radiation. We studied CBLB502, a polypeptide drug derived from Salmonella flagellin that binds to Toll-like receptor 5 (TLR5) and activates nuclear factor-κB signaling. A single injection of CBLB502 before lethal total-body irradiation protected mice from both gastrointestinal and hematopoietic acute radiation syndromes and resulted in improved survival. CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses. It is noteworthy that the drug did not decrease tumor radiosensitivity in mouse models. CBLB502 also showed radioprotective activity in lethally irradiated rhesus monkeys. Thus, TLR5 agonists could potentially improve the therapeutic index of cancer radiotherapy and serve as biological protectants in radiation emergencies.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.1154986</identifier><identifier>PMID: 18403709</identifier><identifier>CODEN: SCIEAS</identifier><language>eng</language><publisher>Washington, DC: American Association for the Advancement of Science</publisher><subject>Agonists ; Amino Acid Sequence ; Animals ; Antineoplastic agents ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - radiation effects ; Biological and medical sciences ; Cellular biology ; Chemotherapy, Adjuvant ; Crypts ; Endothelial cells ; Flagellin - chemistry ; Flagellin - pharmacology ; Gamma Rays ; General aspects ; Hematopoietic System - drug effects ; Hematopoietic System - radiation effects ; Intestine, Small - cytology ; Intestine, Small - drug effects ; Intestine, Small - radiation effects ; Irradiation ; Macaca mulatta ; Medical sciences ; Mice ; Mice, Inbred ICR ; Molecular Sequence Data ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - radiotherapy ; NF-kappa B - metabolism ; Peptides - administration &amp; dosage ; Peptides - chemistry ; Peptides - pharmacology ; Peptides - toxicity ; Pharmacology. Drug treatments ; Primates ; Radiation ; Radiation Dosage ; Radiation Injuries, Experimental - prevention &amp; control ; Radiation protection ; Radiation Tolerance - drug effects ; Radiation-Protective Agents - administration &amp; dosage ; Radiation-Protective Agents - chemistry ; Radiation-Protective Agents - pharmacology ; Radiation-Protective Agents - toxicity ; Radiotherapy ; Rodents ; Salmonella ; Salmonella enterica ; Signal Transduction ; Small intestine ; Stem cells ; Toll-Like Receptor 5 - agonists ; Toll-Like Receptor 5 - metabolism ; Toxicity ; Tumors ; Whole-Body Irradiation</subject><ispartof>Science (American Association for the Advancement of Science), 2008-04, Vol.320 (5873), p.226-230</ispartof><rights>Copyright 2008 American Association for the Advancement of Science</rights><rights>2008 INIST-CNRS</rights><rights>Copyright © 2008, American Association for the Advancement of Science</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c621t-592e29b466eb9c7f9ffc8f4381f2650d7507f9d4b4d316b9e01860b013f903f93</citedby><cites>FETCH-LOGICAL-c621t-592e29b466eb9c7f9ffc8f4381f2650d7507f9d4b4d316b9e01860b013f903f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/20054988$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/20054988$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,2871,2872,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20281874$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18403709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burdelya, Lyudmila G</creatorcontrib><creatorcontrib>Krivokrysenko, Vadim I</creatorcontrib><creatorcontrib>Tallant, Thomas C</creatorcontrib><creatorcontrib>Strom, Evguenia</creatorcontrib><creatorcontrib>Gleiberman, Anatoly S</creatorcontrib><creatorcontrib>Gupta, Damodar</creatorcontrib><creatorcontrib>Kurnasov, Oleg V</creatorcontrib><creatorcontrib>Fort, Farrel L</creatorcontrib><creatorcontrib>Osterman, Andrei L</creatorcontrib><creatorcontrib>DiDonato, Joseph A</creatorcontrib><creatorcontrib>Feinstein, Elena</creatorcontrib><creatorcontrib>Gudkov, Andrei V</creatorcontrib><title>Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models</title><title>Science (American Association for the Advancement of Science)</title><addtitle>Science</addtitle><description>The toxicity of ionizing radiation is associated with massive apoptosis in radiosensitive organs. Here, we investigate whether a drug that activates a signaling mechanism used by tumor cells to suppress apoptosis can protect healthy cells from the harmful effects of radiation. We studied CBLB502, a polypeptide drug derived from Salmonella flagellin that binds to Toll-like receptor 5 (TLR5) and activates nuclear factor-κB signaling. A single injection of CBLB502 before lethal total-body irradiation protected mice from both gastrointestinal and hematopoietic acute radiation syndromes and resulted in improved survival. CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses. It is noteworthy that the drug did not decrease tumor radiosensitivity in mouse models. CBLB502 also showed radioprotective activity in lethally irradiated rhesus monkeys. Thus, TLR5 agonists could potentially improve the therapeutic index of cancer radiotherapy and serve as biological protectants in radiation emergencies.</description><subject>Agonists</subject><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - radiation effects</subject><subject>Biological and medical sciences</subject><subject>Cellular biology</subject><subject>Chemotherapy, Adjuvant</subject><subject>Crypts</subject><subject>Endothelial cells</subject><subject>Flagellin - chemistry</subject><subject>Flagellin - pharmacology</subject><subject>Gamma Rays</subject><subject>General aspects</subject><subject>Hematopoietic System - drug effects</subject><subject>Hematopoietic System - radiation effects</subject><subject>Intestine, Small - cytology</subject><subject>Intestine, Small - drug effects</subject><subject>Intestine, Small - radiation effects</subject><subject>Irradiation</subject><subject>Macaca mulatta</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred ICR</subject><subject>Molecular Sequence Data</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - radiotherapy</subject><subject>NF-kappa B - metabolism</subject><subject>Peptides - administration &amp; dosage</subject><subject>Peptides - chemistry</subject><subject>Peptides - pharmacology</subject><subject>Peptides - toxicity</subject><subject>Pharmacology. Drug treatments</subject><subject>Primates</subject><subject>Radiation</subject><subject>Radiation Dosage</subject><subject>Radiation Injuries, Experimental - prevention &amp; control</subject><subject>Radiation protection</subject><subject>Radiation Tolerance - drug effects</subject><subject>Radiation-Protective Agents - administration &amp; dosage</subject><subject>Radiation-Protective Agents - chemistry</subject><subject>Radiation-Protective Agents - pharmacology</subject><subject>Radiation-Protective Agents - toxicity</subject><subject>Radiotherapy</subject><subject>Rodents</subject><subject>Salmonella</subject><subject>Salmonella enterica</subject><subject>Signal Transduction</subject><subject>Small intestine</subject><subject>Stem cells</subject><subject>Toll-Like Receptor 5 - agonists</subject><subject>Toll-Like Receptor 5 - metabolism</subject><subject>Toxicity</subject><subject>Tumors</subject><subject>Whole-Body Irradiation</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc9rFDEUx4Modq2ePalB0NvYl2Qmk1yEpagVVpTagreQybysWWcnazJb6H9vlh1q9RAeed9P3o98CXnO4B1jXJ5lF3B0WC5NrZV8QBYMdFNpDuIhWQAIWSlomxPyJOcNQNG0eExOmKpBtKAX5MdyHceQJxo9vYrDUK3CL6SX6HA3xUQbemEzvbR9iLsUJ3RTuEG6PIQw3dIw0i9xn5HasaffUtjaCUumxyE_JY-8HTI-m-Mpuf744er8olp9_fT5fLmqnORsqhrNkeuulhI77VqvvXfK10Ixz2UDfdtASfZ1V_eCyU4jMCWhAya8hnLEKXl_rLvbd1vsHY5TsoPZHYZJtybaYP5VxvDTrOONqQXnWjSlwNu5QIq_95gnsw3Z4TDYEctuhoNSrYAD-Po_cBP3aSzLGc5Eo6USbYHOjpBLMeeE_m4SBuZgmZktM7Nl5cXL-wv85WePCvBmBmx2dvDJji7kO44DV0y1deFeHLlNLtbd0-HQSBX91VH3Nhq7TqXG9XdefhLKhqWTEn8AAq-ytA</recordid><startdate>20080411</startdate><enddate>20080411</enddate><creator>Burdelya, Lyudmila G</creator><creator>Krivokrysenko, Vadim I</creator><creator>Tallant, Thomas C</creator><creator>Strom, Evguenia</creator><creator>Gleiberman, Anatoly S</creator><creator>Gupta, Damodar</creator><creator>Kurnasov, Oleg V</creator><creator>Fort, Farrel L</creator><creator>Osterman, Andrei L</creator><creator>DiDonato, Joseph A</creator><creator>Feinstein, Elena</creator><creator>Gudkov, Andrei V</creator><general>American Association for the Advancement of Science</general><general>The American Association for the Advancement of Science</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QQ</scope><scope>7QR</scope><scope>7SC</scope><scope>7SE</scope><scope>7SN</scope><scope>7SP</scope><scope>7SR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7TK</scope><scope>7TM</scope><scope>7U5</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7T5</scope><scope>5PM</scope></search><sort><creationdate>20080411</creationdate><title>Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models</title><author>Burdelya, Lyudmila G ; Krivokrysenko, Vadim I ; Tallant, Thomas C ; Strom, Evguenia ; Gleiberman, Anatoly S ; Gupta, Damodar ; Kurnasov, Oleg V ; Fort, Farrel L ; Osterman, Andrei L ; DiDonato, Joseph A ; Feinstein, Elena ; Gudkov, Andrei V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c621t-592e29b466eb9c7f9ffc8f4381f2650d7507f9d4b4d316b9e01860b013f903f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Agonists</topic><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - radiation effects</topic><topic>Biological and medical sciences</topic><topic>Cellular biology</topic><topic>Chemotherapy, Adjuvant</topic><topic>Crypts</topic><topic>Endothelial cells</topic><topic>Flagellin - chemistry</topic><topic>Flagellin - pharmacology</topic><topic>Gamma Rays</topic><topic>General aspects</topic><topic>Hematopoietic System - drug effects</topic><topic>Hematopoietic System - radiation effects</topic><topic>Intestine, Small - cytology</topic><topic>Intestine, Small - drug effects</topic><topic>Intestine, Small - radiation effects</topic><topic>Irradiation</topic><topic>Macaca mulatta</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred ICR</topic><topic>Molecular Sequence Data</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - radiotherapy</topic><topic>NF-kappa B - metabolism</topic><topic>Peptides - administration &amp; dosage</topic><topic>Peptides - chemistry</topic><topic>Peptides - pharmacology</topic><topic>Peptides - toxicity</topic><topic>Pharmacology. Drug treatments</topic><topic>Primates</topic><topic>Radiation</topic><topic>Radiation Dosage</topic><topic>Radiation Injuries, Experimental - prevention &amp; control</topic><topic>Radiation protection</topic><topic>Radiation Tolerance - drug effects</topic><topic>Radiation-Protective Agents - administration &amp; dosage</topic><topic>Radiation-Protective Agents - chemistry</topic><topic>Radiation-Protective Agents - pharmacology</topic><topic>Radiation-Protective Agents - toxicity</topic><topic>Radiotherapy</topic><topic>Rodents</topic><topic>Salmonella</topic><topic>Salmonella enterica</topic><topic>Signal Transduction</topic><topic>Small intestine</topic><topic>Stem cells</topic><topic>Toll-Like Receptor 5 - agonists</topic><topic>Toll-Like Receptor 5 - metabolism</topic><topic>Toxicity</topic><topic>Tumors</topic><topic>Whole-Body Irradiation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burdelya, Lyudmila G</creatorcontrib><creatorcontrib>Krivokrysenko, Vadim I</creatorcontrib><creatorcontrib>Tallant, Thomas C</creatorcontrib><creatorcontrib>Strom, Evguenia</creatorcontrib><creatorcontrib>Gleiberman, Anatoly S</creatorcontrib><creatorcontrib>Gupta, Damodar</creatorcontrib><creatorcontrib>Kurnasov, Oleg V</creatorcontrib><creatorcontrib>Fort, Farrel L</creatorcontrib><creatorcontrib>Osterman, Andrei L</creatorcontrib><creatorcontrib>DiDonato, Joseph A</creatorcontrib><creatorcontrib>Feinstein, Elena</creatorcontrib><creatorcontrib>Gudkov, Andrei V</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Ecology Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Immunology Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burdelya, Lyudmila G</au><au>Krivokrysenko, Vadim I</au><au>Tallant, Thomas C</au><au>Strom, Evguenia</au><au>Gleiberman, Anatoly S</au><au>Gupta, Damodar</au><au>Kurnasov, Oleg V</au><au>Fort, Farrel L</au><au>Osterman, Andrei L</au><au>DiDonato, Joseph A</au><au>Feinstein, Elena</au><au>Gudkov, Andrei V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><addtitle>Science</addtitle><date>2008-04-11</date><risdate>2008</risdate><volume>320</volume><issue>5873</issue><spage>226</spage><epage>230</epage><pages>226-230</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><coden>SCIEAS</coden><abstract>The toxicity of ionizing radiation is associated with massive apoptosis in radiosensitive organs. Here, we investigate whether a drug that activates a signaling mechanism used by tumor cells to suppress apoptosis can protect healthy cells from the harmful effects of radiation. We studied CBLB502, a polypeptide drug derived from Salmonella flagellin that binds to Toll-like receptor 5 (TLR5) and activates nuclear factor-κB signaling. A single injection of CBLB502 before lethal total-body irradiation protected mice from both gastrointestinal and hematopoietic acute radiation syndromes and resulted in improved survival. CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses. It is noteworthy that the drug did not decrease tumor radiosensitivity in mouse models. CBLB502 also showed radioprotective activity in lethally irradiated rhesus monkeys. Thus, TLR5 agonists could potentially improve the therapeutic index of cancer radiotherapy and serve as biological protectants in radiation emergencies.</abstract><cop>Washington, DC</cop><pub>American Association for the Advancement of Science</pub><pmid>18403709</pmid><doi>10.1126/science.1154986</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 2008-04, Vol.320 (5873), p.226-230
issn 0036-8075
1095-9203
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4322935
source American Association for the Advancement of Science; Jstor Complete Legacy; MEDLINE
subjects Agonists
Amino Acid Sequence
Animals
Antineoplastic agents
Apoptosis
Apoptosis - drug effects
Apoptosis - radiation effects
Biological and medical sciences
Cellular biology
Chemotherapy, Adjuvant
Crypts
Endothelial cells
Flagellin - chemistry
Flagellin - pharmacology
Gamma Rays
General aspects
Hematopoietic System - drug effects
Hematopoietic System - radiation effects
Intestine, Small - cytology
Intestine, Small - drug effects
Intestine, Small - radiation effects
Irradiation
Macaca mulatta
Medical sciences
Mice
Mice, Inbred ICR
Molecular Sequence Data
Neoplasms, Experimental - drug therapy
Neoplasms, Experimental - radiotherapy
NF-kappa B - metabolism
Peptides - administration & dosage
Peptides - chemistry
Peptides - pharmacology
Peptides - toxicity
Pharmacology. Drug treatments
Primates
Radiation
Radiation Dosage
Radiation Injuries, Experimental - prevention & control
Radiation protection
Radiation Tolerance - drug effects
Radiation-Protective Agents - administration & dosage
Radiation-Protective Agents - chemistry
Radiation-Protective Agents - pharmacology
Radiation-Protective Agents - toxicity
Radiotherapy
Rodents
Salmonella
Salmonella enterica
Signal Transduction
Small intestine
Stem cells
Toll-Like Receptor 5 - agonists
Toll-Like Receptor 5 - metabolism
Toxicity
Tumors
Whole-Body Irradiation
title Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A21%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Agonist%20of%20Toll-Like%20Receptor%205%20Has%20Radioprotective%20Activity%20in%20Mouse%20and%20Primate%20Models&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Burdelya,%20Lyudmila%20G&rft.date=2008-04-11&rft.volume=320&rft.issue=5873&rft.spage=226&rft.epage=230&rft.pages=226-230&rft.issn=0036-8075&rft.eissn=1095-9203&rft.coden=SCIEAS&rft_id=info:doi/10.1126/science.1154986&rft_dat=%3Cjstor_pubme%3E20054988%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213596837&rft_id=info:pmid/18403709&rft_jstor_id=20054988&rfr_iscdi=true